Frankfurt - Delayed Quote EUR
Fate Therapeutics, Inc. (F6T.F)
1.1715
+0.0245
+(2.14%)
As of 8:25:37 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 10 | 9 |
| Avg. Estimate | 1.18M | 1.18M | 4.59M | 4.58M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 3.4M | 3.4M | 13.6M | 13.6M |
| Year Ago Sales | 1.93M | 6.77M | 13.63M | 4.59M |
| Sales Growth (year/est) | -38.47% | -82.56% | -66.32% | -0.22% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| F6T.F | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Maintains | Stifel: Hold to Hold | 3/6/2025 |
| Reiterates | Wedbush: Neutral to Neutral | 3/6/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 3/6/2025 |
| Reiterates | Needham: Hold to Hold | 3/6/2025 |
| Reiterates | Needham: Hold | 11/19/2024 |
| Reiterates | Needham: Hold | 11/13/2024 |
Related Tickers
AVU0.F Adverum Biotechnologies, Inc.
2.5800
+4.88%
HXBM Helix BioMedix, Inc.
7.18
0.00%
1JK.F Apellis Pharmaceuticals, Inc.
14.81
-6.25%
1T3.F Syndax Pharmaceuticals, Inc.
11.50
+2.68%
38I.F Intellia Therapeutics, Inc.
6.98
+4.18%
CDTTW Conduit Pharmaceuticals Inc.
0.0115
+53.33%
ANTX AN2 Therapeutics, Inc.
1.2500
-3.10%
TYRA Tyra Biosciences, Inc.
9.98
-1.09%
SION Sionna Therapeutics, Inc.
12.27
-2.62%
KYTX Kyverna Therapeutics, Inc.
2.1400
0.00%